New early blood screening tests for Down's syndrome
This article was originally published in Clinica
Researchers in Belgium have developed an early maternal blood screening test for Down's syndrome. The test, which can be performed between the tenth and twentieth week of pregnancy, could help doctors cut down the number of unnecessary amniocentesis tests, which carry a small risk of miscarriage.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.